Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease

Abstract Smartphones and wearables are widely recognised as the foundation for novel Digital Health Technologies (DHTs) for the clinical assessment of Parkinson’s disease. Yet, only limited progress has been made towards their regulatory acceptability as effective drug development tools. A key barri...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: George Roussos, Teresa Ruiz Herrero, Derek L. Hill, Ariel V. Dowling, Martijn L. T. M. Müller, Luc J. W. Evers, Jackson Burton, Adrian Derungs, Katherine Fisher, Krishna Praneeth Kilambi, Nitin Mehrotra, Roopal Bhatnagar, Sakshi Sardar, Diane Stephenson, Jamie L. Adams, E. Ray Dorsey, Josh Cosman
Format: Artikel
Sprache:English
Veröffentlicht: Nature Portfolio 2022-07-01
Schriftenreihe:npj Digital Medicine
Online Zugang:https://doi.org/10.1038/s41746-022-00643-4